Ligand Pharmaceuticals | LGND - Umsatzkosten





Umsatzkosten Veränderung Datum
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 1.81B 587M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 2.94B 380M 2026-03
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 38.49M 794K 2026-03